NDC 0173-0867

Tanzeum

Albiglutide

Tanzeum is a Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Albiglutide.

Product ID0173-0867_547b7089-3a91-4bb4-8881-e1abfbe39e82
NDC0173-0867
Product TypeHuman Prescription Drug
Proprietary NameTanzeum
Generic NameAlbiglutide
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2014-04-15
Marketing End Date2020-08-31
Marketing CategoryBLA / BLA
Application NumberBLA125431
Labeler NameGlaxoSmithKline LLC
Substance NameALBIGLUTIDE
Active Ingredient Strength50 mg/.5mL
Pharm ClassesGlucagon-like Peptide-1 (GLP-1) Agonists [MoA],GLP-1 Receptor Agonist [EPC]
NDC Exclude FlagN

Packaging

NDC 0173-0867-02

1 SYRINGE in 1 CARTON (0173-0867-02) > .5 mL in 1 SYRINGE
Marketing Start Date2014-04-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0173-0867-35 [00173086735]

Tanzeum INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryBLA
Application NumberBLA125431
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-04-15
Marketing End Date2020-08-31

NDC 0173-0867-02 [00173086702]

Tanzeum INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryBLA
Application NumberBLA125431
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-04-15
Marketing End Date2019-07-31

NDC 0173-0867-01 [00173086701]

Tanzeum INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryBLA
Application NumberBLA125431
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-04-27
Marketing End Date2020-08-31

NDC 0173-0867-61 [00173086761]

Tanzeum INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryBLA
Application NumberBLA125431
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-05-29
Marketing End Date2019-08-31

Drug Details

Active Ingredients

IngredientStrength
ALBIGLUTIDE50 mg/.5mL

OpenFDA Data

SPL SET ID:5fcad939-76e7-49cf-af94-4e6aef17901f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1534820
  • 1534800
  • 1534822
  • 1534805
  • Pharmacological Class

    • Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
    • GLP-1 Receptor Agonist [EPC]
    • Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
    • GLP-1 Receptor Agonist [EPC]

    NDC Crossover Matching brand name "Tanzeum" or generic name "Albiglutide"

    NDCBrand NameGeneric Name
    0173-0866Tanzeumalbiglutide
    0173-0867Tanzeumalbiglutide

    Trademark Results [Tanzeum]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TANZEUM
    TANZEUM
    85455155 4667891 Live/Registered
    Glaxo Group Limited
    2011-10-25
    TANZEUM
    TANZEUM
    77432328 not registered Dead/Abandoned
    Glaxo Group Limited
    2008-03-26

    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.